What is NOCO Drug Testing?
NOCO Drug Testing operates as a specialized provider of 24/7 accredited drug and alcohol screening services, serving a diverse clientele that spans both corporate employers and private individuals. With a legacy exceeding 35 years, the organization has cemented its market position by offering comprehensive DOT and non-DOT drug screens, alongside essential policy review and safety training. By integrating a proprietary management framework, the company ensures high-fidelity, timely results, which are critical for maintaining workplace safety standards and legal compliance in a highly regulated environment. Their focus on reliability and professional expertise distinguishes them as a cornerstone of the Northern Colorado occupational health sector.
How much funding has NOCO Drug Testing raised?
NOCO Drug Testing has raised a total of $11K across 1 funding round:
Debt
$11K
Debt (2021): $11K with participation from PPP
Key Investors in NOCO Drug Testing
PPP
Public-Private Partnership
What's next for NOCO Drug Testing?
With the recent influx of growth capital, NOCO Drug Testing is well-positioned to accelerate its market penetration and enhance its service delivery infrastructure. The company is expected to leverage this investment to refine its digital management platforms and potentially expand its service reach beyond its current regional stronghold. As the demand for rigorous workplace compliance and safety protocols continues to rise, the firm's strategic focus will likely shift toward optimizing operational efficiency and scaling its testing capacity to meet the evolving needs of its enterprise partners. This growth phase underscores the company's commitment to maintaining its leadership status in the drug and alcohol testing industry while navigating the complexities of modern regulatory landscapes.
See full NOCO Drug Testing company page
